HoldsUp

Dale Bredesen

Dale Bredesen is a researcher whose work focuses on cognitive decline and Alzheimer's disease. His published research investigates precision medicine and multi-factorial interventions, including dietary protocols such as the KetoFLEX 12/3 diet and personalized therapeutic programs. Additionally, his studies explore molecular mechanisms, metabolic pathways, and targeted pharmacological agents for Alzheimer's disease.

31 claims checked on air: 3 context 1 contradicted 4 overstated 19 supported 4 unverified

What they said on air - citing their own research

2 citing their own research

0:05:53overstatedvery lowtheir own paperHow to Make Your Brain Ageless: Prevent Cognitive Decline &

A published paper demonstrates over a decade of sustained cognitive and MRI improvement in patients treated with a precision medicine approach for cognitive decline.

"we just published a paper freely available online, over a decade of improvement in some of these people—then you can't really deny it." (said at 0:05:53)

A 2024 open-access case series reported sustained cognitive improvement spanning up to a decade in selected patients undergoing a personalized, multi-component precision medicine protocol (the ReCODE protocol). However, presenting an uncontrolled case series as undeniable proof of treatment efficacy overstates the scientific strength of the evidence. Uncontrolled case series cannot rule out selection bias, practice effects, natural fluctuation, or concurrent confounders, and the study authors themselves noted that controlled, long-term cohort studies are required to establish efficacy and frequency of response.

1:06:17supportedvery lowtheir own paperHow to Make Your Brain Ageless: Prevent Cognitive Decline &

Expressing human Alzheimer's genes in Drosophila fruit flies generated an ADHD-like phenotype with hyperactivity that responded to dextroamphetamine.

"When we put human Alzheimer genes into fruit flies, guess what? They didn't get Alzheimer's, they got ADHD. And this is published. They fit all criteria. They were more in males. It was treated by the same drugs like dextroamphetamine beautifully. They had increased movement all the time." (said at 1:06:17)

A 2015 study published in the Journal of Neurology & Neurophysiology reported that an invertebrate Drosophila melanogaster Alzheimer's model exhibited features analogous to attention deficit hyperactivity disorder (ADHD), including hyperactivity, male predominance, and a reversible response to dextroamphetamine. Because the evidence is derived solely from an animal (invertebrate) model in a single preliminary report, the certainty of evidence for human clinical implications is very low.

Fact-checked episodes

Publications